ReviewDrug design, development and therapy2017

Inhibitors of the PD-1/PD-L1 axis for the treatment of head and neck cancer: current status and future perspectives.

Xiongwen Ran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.